MannKind Corporation (NASDAQ:MNKD) is one of the 13 Stocks Under $5 With High Upside Potential. On June 27, analyst Yun Zhong from Wedbush maintained a Buy rating on MannKind Corporation (NASDAQ:MNKD) ...

MannKind Corporation (NASDAQ:MNKD) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. On June 19, analyst Faisal Khurshid of Leerink Partners reiterated a Buy rating on ...

MannKind (MNKD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MannKind (MNKD) reported $70.08 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 36.7%. EPS of $0.04 for the same period compares to $0.02 a year ago.

If MNKD’s multiple moves to the industry average, this translates to a value of $10.50 per share for MNKD. Last year, when MNKD was trading at $11, this wasn’t a good deal.

Investors in MannKind Corp (Symbol: MNKD) saw new options become available this week, for the September 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

MannKind Corp.MNKD-1.05%decrease; red down pointing triangle on Tuesday announced the termination of its licensing pact with Sanofi-Aventis in the U.S. for the development and sale of its inhaled ...